Diseases with the highest burden for society such as stroke, myocardial infarction, pulmonary embolism, and others are due to blood clots. Preclinical and clinical techniques to study blood clots are important tools for translational research of new diagnostic and therapeutic modalities that target blood clots. In this study, we employed a three-dimensional (3D) printed middle cerebral artery model to image clots under flow conditions using preclinical imaging techniques including fluorescent whole-body imaging, magnetic resonance imaging (MRI), and computed X-ray microtomography (microCT). Both liposome-based, fibrin-targeted, and non-targeted contrast agents were proven to provide a sufficient signal for clot imaging within the model under flow conditions. The application of the model for clot targeting studies and thrombolytic studies using preclinical imaging techniques is shown here. For the first time, a novel method of thrombus labeling utilizing barium sulphate (Micropaque®) is presented here as an example of successfully employed contrast agents for in vitro experiments evaluating the time-course of thrombolysis and thus the efficacy of a thrombolytic drug, recombinant tissue plasminogen activator (rtPA). Finally, the proof-of-concept of in vivo clot imaging in a middle cerebral artery occlusion (MCAO) rat model using barium sulphate-labelled clots is presented, confirming the great potential of such an approach to make experiments comparable between in vitro and in vivo models, finally leading to a reduction in animals needed.

Department of Pharmacology and Toxicology Masaryk University Žerotínovo náměstí 617 9 601 77 Brno Czech Republic Stroke Research Program International Clinical Research Center St Anne's University Hospital Pekařská 53 656 91 Brno Czech Republic

Department of Pharmacology and Toxicology Veterinary Research Institute Hudcova 296 70 621 00 Brno Czech Republic

Department of Pharmacology and Toxicology Veterinary Research Institute Hudcova 296 70 621 00 Brno Czech Republic Institute of Physics Czech Academy of Sciences Na Slovance 1999 2 182 21 Prague Czech Republic

Institute of Scientific Instruments of the Czech Academy of Sciences Královopolská 147 612 64 Brno Czech Republic

Laboratory of Ligand Engineering Institute of Biotechnology of the Czech Academy of Sciences v v i BIOCEV Research Center Průmyslová 595 252 50 Vestec Czech Republic

Stroke Research Program International Clinical Research Center St Anne's University Hospital Pekařská 53 656 91 Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc21001551

003      

CZ-PrNML

005      

20210126092818.0

007      

ta

008      

210105s2020 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/pharmaceutics12121207 $2 doi

035    __

$a (PubMed)33322710

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Vítečková Wünschová, Andrea $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.

245    10

$a Thrombus Imaging Using 3D Printed Middle Cerebral Artery Model and Preclinical Imaging Techniques: Application to Thrombus Targeting and Thrombolytic Studies. / $c A. Vítečková Wünschová, A. Novobilský, J. Hložková, P. Scheer, H. Petroková, R. Jiřík, P. Kulich, E. Bartheldyová, F. Hubatka, V. Jonas, R. Mikulík, P. Malý, J. Turánek, J. Mašek,

520    9_

$a Diseases with the highest burden for society such as stroke, myocardial infarction, pulmonary embolism, and others are due to blood clots. Preclinical and clinical techniques to study blood clots are important tools for translational research of new diagnostic and therapeutic modalities that target blood clots. In this study, we employed a three-dimensional (3D) printed middle cerebral artery model to image clots under flow conditions using preclinical imaging techniques including fluorescent whole-body imaging, magnetic resonance imaging (MRI), and computed X-ray microtomography (microCT). Both liposome-based, fibrin-targeted, and non-targeted contrast agents were proven to provide a sufficient signal for clot imaging within the model under flow conditions. The application of the model for clot targeting studies and thrombolytic studies using preclinical imaging techniques is shown here. For the first time, a novel method of thrombus labeling utilizing barium sulphate (Micropaque®) is presented here as an example of successfully employed contrast agents for in vitro experiments evaluating the time-course of thrombolysis and thus the efficacy of a thrombolytic drug, recombinant tissue plasminogen activator (rtPA). Finally, the proof-of-concept of in vivo clot imaging in a middle cerebral artery occlusion (MCAO) rat model using barium sulphate-labelled clots is presented, confirming the great potential of such an approach to make experiments comparable between in vitro and in vivo models, finally leading to a reduction in animals needed.

655    _2

$a časopisecké články $7 D016428

700    1_

$a Novobilský, Adam $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.

700    1_

$a Hložková, Jana $u Department of Pharmacology and Toxicology, Masaryk University, Žerotínovo náměstí 617/9, 601 77 Brno, Czech Republic. Stroke Research Program, International Clinical Research Center St. Anne's University Hospital, Pekařská 53, 656 91 Brno, Czech Republic.

700    1_

$a Scheer, Peter $u Department of Pharmacology and Toxicology, Masaryk University, Žerotínovo náměstí 617/9, 601 77 Brno, Czech Republic. Stroke Research Program, International Clinical Research Center St. Anne's University Hospital, Pekařská 53, 656 91 Brno, Czech Republic.

700    1_

$a Petroková, Hana $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v.v.i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic.

700    1_

$a Jiřík, Radovan $u Institute of Scientific Instruments of the Czech Academy of Sciences, Královopolská 147, 612 64 Brno, Czech Republic.

700    1_

$a Kulich, Pavel $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.

700    1_

$a Bartheldyová, Eliška $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.

700    1_

$a Hubatka, František $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.

700    1_

$a Jonas, Vladimír $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.

700    1_

$a Mikulík, Robert $u Stroke Research Program, International Clinical Research Center St. Anne's University Hospital, Pekařská 53, 656 91 Brno, Czech Republic.

700    1_

$a Malý, Petr $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v.v.i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic.

700    1_

$a Turánek, Jaroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic. Institute of Physics, Czech Academy of Sciences, Na Slovance 1999/2, 182 21 Prague, Czech Republic.

700    1_

$a Mašek, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.

773    0_

$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 12, č. 12 (2020)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/33322710 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20210105 $b ABA008

991    __

$a 20210126092814 $b ABA008

999    __

$a ind $b bmc $g 1613929 $s 1121835

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2020 $b 12 $c 12 $e 20201212 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380

GRA    __

$a 16-30299A $p Ministerstvo Zdravotnictví Ceské Republiky

GRA    __

$a CZ.02.1.01/0.0/0.0/15_003/0000495 $p Ministerstvo Školství, Mládeže a Tělovýchovy

GRA    __

$a CZ.02.1.01/0.0/0.0/16_025/0007397 $p Ministerstvo Školství, Mládeže a Tělovýchovy

GRA    __

$a 318/2019/FaF $p IGA VFU

GRA    __

$a RO0518 $p Ministerstvo Zemědělství

GRA    __

$a 86652036 $p Institutional Research Concept RVO

GRA    __

$a NV16-30299A $p MZ0

LZP    __

$a Pubmed-20210105